|
|
|
Volumn 31, Issue 9, 2004, Pages 1309-1313
|
|
Tumor suppressor gene p53 and molecular targeting therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,2 BIS(HYDROXYMETHYL) 1 AZABICYCLO(2,2,2,)OCTAN 3 ONE;
2,2-BIS(HYDROXYMETHYL)-1-AZABICYCLO(2,2,2,)OCTAN-3-ONE;
4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE;
FAS LIGAND;
FASLG PROTEIN, HUMAN;
FUSED HETEROCYCLIC RINGS;
HETEROCYCLIC COMPOUND;
MEMBRANE PROTEIN;
ONCOPROTEIN;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN P53;
PYRIMIDINE DERIVATIVE;
APOPTOSIS;
GENE TARGETING;
GENE THERAPY;
GENETICS;
HUMAN;
METABOLISM;
NEOPLASM;
REVIEW;
TUMOR SUPPRESSOR GENE;
APOPTOSIS;
AZA COMPOUNDS;
BCL-2-ASSOCIATED X PROTEIN;
BICYCLO COMPOUNDS, HETEROCYCLIC;
FAS LIGAND PROTEIN;
GENE TARGETING;
GENE THERAPY;
GENES, P53;
HUMANS;
MEMBRANE GLYCOPROTEINS;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PYRIMIDINES;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 4644370485
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (23)
|
